Menu
Log in


Patent Information Users Group, Inc.

The International Society for Patent Information Professionals

Log in

2021 World IP Forum, Apr. 26 –May 5, 2021: Patent search/patent analytics & AI; FTO, patent opposition/IPR proceedings, pharmaceutical patents, inventive step, IP law updates, etc.

  • 23 Apr 2021 11:58 PM
    Message # 10344600

    Intellectual Professionals LLP (India) organized three-days(?) 9th 2021 World IP Forum which attracted many distinguished speakers from around the globe. Below are selected presentation taken from the referenced speaker list. Detailed program is restricted to those who sign up to  a conference web-site.

    Topics include patent search & AI; patent analytics & AI, FTO, patent opposition/IPR proceedings, pharmaceutical patents, inventive step/obviousness, IP law updates, etc.

    Registration link. Fees: $120 (access to technical sessions, 8AM-1PM EST] or $220 (+access for recordings during 10 days).

     

    Patent Search

    Applying AI to IP Search, Trends and Use Cases, Susan A Hallen, IP Management Solutions Manager, IBM Corporation, USA

    What happens when prior art search is fast, easy, and fun? Sam Davis , CEO & Founder and Matthew Luby, Head of Client Services, Amplified, Japan

    AI and Machine Learning in Patent Search Systems: Friend or Foe? Brad Buehler, COO and Jonathan Skovholt, Head of Patent Search Operations, Ensemble IP LLC, USA (was on the program of  2020 PIUG conference)

    INTERGATOR Smart Search: Re-thinking of Patent Searching using Machine Learning, Heiko Wongel, Founder, Wongel IP,  Germany

     

    Session: Patent Discovery: If willful blindness and AI had a child, would it be good, bad or ugly?
    Susanne Hantos,
    Senior Patent Counsel, Davies Collison Cave, Australia
    Bettina de Jong, Secretary General of the PDG & Chairperson ISBQPIP, Netherlands
    Sandra Mau Vice President - Cloud Solutions, Clarivate, USA
    Doris Spielthenner, Co-Founder and President, Ambercite Australia
    Audrey Yap, President at LESI & Managing Partner, Yusarn Audrey, Singapore


    Patent Analytics

    The future of patent analytics, Anna Maria Villa, Patent Expert, IPI - Federal Institute of Intellectual Property, Switzerland

    Session: Patent Analytics - Current and Future (with AI & ML)
    Al Etheridge,
    Founder, Atlanta Patent Services (APS), USA
    Steve Harris, CTO, Cipher, UK
    Madhav Kulkarni, Global Intellectual Capital Manager, Dow, India
    Prateek Mohunta, COO, Sagacious IP, India
    Jitin Talwar, Founder, XLPAT - TT Consultants, India


    ---------------------

    Session: Meet the editors of World Patent Information
    Jane List, Founder at Extract Information & Editor in Chief  World Patent Information, UK
    Prof. Dr. Martin G. Moehrle, Director of the IPMI at University of Bremen & Associate Editor, World Patent Information, Germany
    Prof. Amy J. C. Trappey, Distinguished Professor at National Tsing Hua University & Associate Editor World Patent Information, Taiwan
    -------------

    Introducing ML4Patents.com a comprehensive resource for learning about the use of machine  learning methods for Intellectual Property, Anthony Trippe, Managing Director, Patinformatics, LLC (also on the program of 2021 PIUG conference)


    The impact of AI on the IP ecosystem, George Koomullil , Founder and CEO , Relecura Inc., USA

    ----------

    FTO

    Disclosure-Dedication Doctrine: A primer on the potential pitfalls of this U.S. form of non-infringement. Jeffrey Alan Hovden, Robins Kaplan LLP, USA
    (see also: Hovden, J.A., Langer, O., McElveen, K., Pinahs, Eagle Pharms. Inc. v. Slayback Pharma LLC. Legal Updates. Robins Kaplan LLP. May 08, 2020.)


    Opposition/IPR proceedings

    Current trends in U.S. Inter Parties review proceedings before the US Patent Office, Christopher Scharff, Shareholde, McAndrews, Held & Malloy, Ltd.,USA

    Using EPO Opposition files in US disputes. Edward J. Kelly, Ropes & Gray LLP, USA

    Oppositions at the EPO. Laura Fe, Murgitroyd, Germany
    (See also: Preparing for Opposition: A guide to conducting effective Opposition and Appeal Proceedings at the European Patent Office. Murgitroyd & Company November 2020. Proprietor’s Guide. 5 p. & Opponent’s Guide. 5 p.)

    Andean Oppositions and Cancellations, Maria Cecilia Romoleroux, CorralRosales, Ecuador

    An Evaluation of the Indian Patent Invalidation Model: Lessons for the Other WTO Member States. Muhammad Zaheer Abbas, Queensland University of Technology, Australia
    (See also Abbas, M.Z., Community-based patent opposition model in India: Access to medicines, right to health and sustainable development. Ph.D Thesis.Queensland University of Technology. April 2020, 371 p. https://eprints.qut.edu.au/180843/

    Session: Patent office invalidation options in Japan, Australia, Singapore, and New Zealand – How to weigh up the options?
    Hiroyuki Hashimoto, Shiga International Patent Office, Japan
    Tracey Hendy, FPA Patent Attorneys, Australia
    Desmond Tan, FPA Patent Attorneys, Singapore


    Pharmaceutical Patents

    Protection of chemical/biotech inventions in Japan with a comparative view. Minoru Kato, Minoru Kato Patent Attorney Firm, Japan

    Current Developments in Vaccine and Pharmaceutical Patents in the US and China. Thomas T. Moga, Dykema Gossett PLLC, USA

    Certificates of Supplementary Protection in Canada, Charles Boulakia, Ridout & Maybee LLP, Canada

    Practical experiences of dealing with the Singapore patent linkage system. James Kinnaird, Marks & Clerk Singapore LLP, Singapore

    Patenting Antibodies in the United States. Lisa L. Mueller, Casimir Jones, S.C., USA

    Session: COVID-19 Medical IP Landscape: Western medicine vs Traditional Chinese Therapy
    Prof. I-Hsin Lin, Buddhist Tzu Chi Hospital,Taiwan
    Prof. Yun Ken, National Taiwan University of Science and Technology,
    Taiwan
    Topic:
    COVID-19 Medical IP Landscape: Western medicine vs Traditional Chinese Therapy
    Prof. Dr. Mei-Hsin Wang, Fellow, Royal Society of Chemistry, UK, Taiwan
    Yueh-Lung Yang,Chang Gung Memorial Hospital, Taiwan


    Inventive Step/Obviousness

    Inventive step assessment at the EPO: The “purpose” - and its surprising consequences, Sabrina Duschner, Liane Heinze, Gerold Schick,  and Corinna Sundermann, Fresenius Kabi, Deutschland GmbH,  Germany

    Developments in Obviousness Law in the United States — inherency and the Role of Secondary Considerations/Objective Indicia, Joseph M. Reisman, Knobbe, Martens, Olson & Bear, LLP, USA


    IP Law Updates

    Session: Updates on European IP law and IP challenges in 2021.
    Sedzimir Chmurzynski and Justyna Rechnio, Polpharma S.A.,Poland
    Karin Pramberger, Polpharma Group, Switzerland
    Maria Pique Rivero, Farmaprojects SAU, Spain

    German Patent Legislation Developments.Prof. Dr. Heinz Goddar, Boehmert & Boehmert, Germany

    Legislation Update on French IP Law. Olivier Nicolle, IP/ON Global Law Firm. France

    Patent Subject Matter Eligibility in the United States. Robert L. Stoll, Faegre Drinker Biddle & Reath LLP, USA

    Canada’s new guidelines on patentable subject matter. Elliott Simcoe, Smart & Biggar, Canada

    Session: IP in Emerging Markets: News from Brazil, India, Pakistan, Russia, South Africa & UAE
    Larisa Lysenko, Dennemeyer Group, Russia
    Suchi Rai, Dennemeyer Group, India
    Christophe Van Zyl, Dennemeyer Group,
    South Africa
    Claudio Szabas, Dennemeyer Group,
    Brazil
    Jan Wrede, Dennemeyer Group,
    UAE

    Beyond the Bay of Bengal: IP Rights in ASEAN (Malaysia & Myanmar Focus) P. Kandiah, KASS International Sdn Bhd, Malaysia

    Vietnam'S IP Landscape 2020: IP Law Changes under Newly-Signed FTAS. Yen Pham, Schmitt & Orlov, Vietnam

     


    Last modified: 26 Apr 2021 9:23 AM | Anonymous member

© 2021 The Patent Information Users Group, Inc.   

Mailing Address:  40 E. Main St., #1438

Newark, DE  19711

Phone: +1 (302) 660-3275   Fax: +1 (302) 660-3276

Email: PIUGinfo@piug.org

Webmaster: webmaster@piug.org

Follow PIUG:  

 

Go to PIUG TwitterGo to PIUG LinkedIn

Notice on use of PIUG name and logo:  

No one may use the PIUG name or logo for any promotional or commercial purpose or any other purpose without the prior written consent of the PIUG Board of Directors.  

Powered by Wild Apricot Membership Software